JP2013514837A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013514837A5 JP2013514837A5 JP2012544930A JP2012544930A JP2013514837A5 JP 2013514837 A5 JP2013514837 A5 JP 2013514837A5 JP 2012544930 A JP2012544930 A JP 2012544930A JP 2012544930 A JP2012544930 A JP 2012544930A JP 2013514837 A5 JP2013514837 A5 JP 2013514837A5
- Authority
- JP
- Japan
- Prior art keywords
- shape
- elastic body
- drug
- less
- dimension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013583 drug formulation Substances 0.000 claims 8
- 229940079593 drug Drugs 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 210000003708 urethra Anatomy 0.000 claims 3
- 230000029142 excretion Effects 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- XIQVNETUBQGFHX-UHFFFAOYSA-N Ditropan Chemical compound C=1C=CC=CC=1C(O)(C(=O)OCC#CCN(CC)CC)C1CCCCC1 XIQVNETUBQGFHX-UHFFFAOYSA-N 0.000 claims 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims 1
- 230000003444 anaesthetic effect Effects 0.000 claims 1
- 230000000202 analgesic effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000013270 controlled release Methods 0.000 claims 1
- 238000009792 diffusion process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000013013 elastic material Substances 0.000 claims 1
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims 1
- 229960005277 gemcitabine Drugs 0.000 claims 1
- 229960004194 lidocaine Drugs 0.000 claims 1
- 230000003204 osmotic effect Effects 0.000 claims 1
- 229960005434 oxybutynin Drugs 0.000 claims 1
- 229920002635 polyurethane Polymers 0.000 claims 1
- 239000004814 polyurethane Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 229960001491 trospium Drugs 0.000 claims 1
- OYYDSUSKLWTMMQ-JKHIJQBDSA-N trospium Chemical compound [N+]12([C@@H]3CC[C@H]2C[C@H](C3)OC(=O)C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CCCC1 OYYDSUSKLWTMMQ-JKHIJQBDSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28764909P | 2009-12-17 | 2009-12-17 | |
| US61/287,649 | 2009-12-17 | ||
| US32571310P | 2010-04-19 | 2010-04-19 | |
| US61/325,713 | 2010-04-19 | ||
| PCT/US2010/061161 WO2011084712A1 (en) | 2009-12-17 | 2010-12-17 | Implantable device with intravesical tolerability and methods of treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015209758A Division JP6247270B2 (ja) | 2009-12-17 | 2015-10-26 | 膀胱内における耐容性を備えた植込み型装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013514837A JP2013514837A (ja) | 2013-05-02 |
| JP2013514837A5 true JP2013514837A5 (OSRAM) | 2014-02-13 |
Family
ID=43769298
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012544930A Pending JP2013514837A (ja) | 2009-12-17 | 2010-12-17 | 膀胱内における耐容性を備えた植込み型装置及び治療方法 |
| JP2015209758A Active JP6247270B2 (ja) | 2009-12-17 | 2015-10-26 | 膀胱内における耐容性を備えた植込み型装置 |
| JP2017147685A Active JP6854210B2 (ja) | 2009-12-17 | 2017-07-31 | 膀胱内における耐容性を備えた植込み型装置及び治療方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015209758A Active JP6247270B2 (ja) | 2009-12-17 | 2015-10-26 | 膀胱内における耐容性を備えた植込み型装置 |
| JP2017147685A Active JP6854210B2 (ja) | 2009-12-17 | 2017-07-31 | 膀胱内における耐容性を備えた植込み型装置及び治療方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US8679094B2 (OSRAM) |
| EP (2) | EP3884988B1 (OSRAM) |
| JP (3) | JP2013514837A (OSRAM) |
| AU (1) | AU2010339821B2 (OSRAM) |
| CA (1) | CA2784601C (OSRAM) |
| CY (1) | CY1124354T1 (OSRAM) |
| DK (2) | DK2512581T3 (OSRAM) |
| ES (2) | ES2867399T3 (OSRAM) |
| FI (1) | FI3884988T3 (OSRAM) |
| HR (2) | HRP20210329T1 (OSRAM) |
| HU (1) | HUE053888T2 (OSRAM) |
| LT (2) | LT3884988T (OSRAM) |
| PL (2) | PL2512581T3 (OSRAM) |
| PT (2) | PT2512581T (OSRAM) |
| RS (2) | RS67130B1 (OSRAM) |
| SI (2) | SI3884988T1 (OSRAM) |
| SM (2) | SMT202100236T1 (OSRAM) |
| WO (1) | WO2011084712A1 (OSRAM) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10925587B2 (en) | 2005-05-20 | 2021-02-23 | Neotract, Inc. | Anchor delivery system |
| US9549739B2 (en) | 2005-05-20 | 2017-01-24 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| US10195014B2 (en) | 2005-05-20 | 2019-02-05 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
| US8668705B2 (en) | 2005-05-20 | 2014-03-11 | Neotract, Inc. | Latching anchor device |
| US8603106B2 (en) | 2005-05-20 | 2013-12-10 | Neotract, Inc. | Integrated handle assembly for anchor delivery system |
| US7645286B2 (en) | 2005-05-20 | 2010-01-12 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
| US8628542B2 (en) | 2005-05-20 | 2014-01-14 | Neotract, Inc. | Median lobe destruction apparatus and method |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| EP3884988B1 (en) * | 2009-12-17 | 2025-06-18 | TARIS Biomedical LLC | Implantable device with intravesical tolerability |
| US20110218488A1 (en) * | 2010-03-05 | 2011-09-08 | Taris Biomedical, Inc. | Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites |
| WO2011159912A2 (en) * | 2010-06-16 | 2011-12-22 | Piekny Mark G | Self-coiling apparatus |
| EP2600800B1 (en) | 2010-08-05 | 2020-09-30 | TARIS Biomedical LLC | Ureteral stent drug delivery device and kit |
| US8690840B2 (en) | 2010-10-06 | 2014-04-08 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
| US9457176B2 (en) | 2010-10-06 | 2016-10-04 | Taris Biomedical Llc | Implantable drug delivery device with bladder retention feature |
| US8679093B2 (en) | 2010-11-23 | 2014-03-25 | Microchips, Inc. | Multi-dose drug delivery device and method |
| AU2012205654B2 (en) | 2011-01-10 | 2016-09-08 | Allergan, Inc. | Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding |
| CA2825399A1 (en) | 2011-02-04 | 2012-08-09 | Taris Biomedical, Inc. | Implantable device for controlled release of low solubility drug |
| US10292801B2 (en) | 2012-03-29 | 2019-05-21 | Neotract, Inc. | System for delivering anchors for treating incontinence |
| US10610294B2 (en) | 2012-04-22 | 2020-04-07 | Newuro, B.V. | Devices and methods for transurethral bladder partitioning |
| US9883906B2 (en) | 2012-04-22 | 2018-02-06 | Newuro, B.V. | Bladder tissue modification for overactive bladder disorders |
| AU2013256500B2 (en) * | 2012-04-30 | 2018-02-08 | Allergan, Inc. | Methods for treatment of pelvic pain and / or comorbid conditions |
| CN112169134B (zh) | 2012-05-19 | 2022-11-29 | 塔里斯生物医药公司 | 具有改良取回特征的可植入泌尿器械 |
| US10130353B2 (en) | 2012-06-29 | 2018-11-20 | Neotract, Inc. | Flexible system for delivering an anchor |
| MX367070B (es) | 2012-08-31 | 2019-08-05 | Taris Biomedical Llc | Sistemas de administracion de farmaco y metodos para el tratamiento de la prostata. |
| SI2890384T1 (sl) | 2012-08-31 | 2022-02-28 | Taris Biomedical Llc | Sistemi za dostavo zdravila in postopki za zdravljenje raka sečnega mehurja, ki obsegajo oksaliplatin |
| WO2014047221A1 (en) | 2012-09-18 | 2014-03-27 | Taris Biomedical, Inc. | Drug delivery systems and methods for treatment of bladder voiding dysfunction|and other lower urinary tract disorders by using trospium |
| US10137287B2 (en) | 2013-03-05 | 2018-11-27 | Taris Biomedical Llc | Drug delivery devices and methods for controlled drug release through device orifice |
| JP6517186B2 (ja) | 2013-03-15 | 2019-05-22 | タリス バイオメディカル エルエルシー | 薬物透過性構成部材を備えた薬物送達デバイス、及び方法 |
| CA2902556C (en) * | 2013-03-15 | 2021-06-22 | Heejin Lee | Drug delivery devices and methods for drug delivery |
| CA2919215C (en) | 2013-08-19 | 2022-11-29 | Taris Biomedical Llc | Multi-unit drug delivery devices and methods |
| WO2015069723A1 (en) | 2013-11-05 | 2015-05-14 | Taris Biomedical Llc | Osmotic drug delivery devices, kits, and methods |
| MX2016011333A (es) * | 2014-03-06 | 2016-12-07 | Taris Biomedical Llc | Sistemas de administracion de farmaco y metodo para el tratamiento de cancer de vejiga con gemcitabina. |
| ES2849562T3 (es) | 2014-05-12 | 2021-08-19 | Taris Biomedical Llc | Dispositivos de administración de fármacos |
| JP6856380B2 (ja) * | 2014-06-26 | 2021-04-07 | タリス バイオメディカル エルエルシー | 弾性ポリマー−薬物マトリックス系を含む膀胱内薬物送達デバイス及び方法 |
| WO2016040904A1 (en) | 2014-09-12 | 2016-03-17 | Taris Biomedical Llc | Ph-modulating drug delivery devices and methods |
| JP6743041B2 (ja) | 2015-03-30 | 2020-08-19 | タリス バイオメディカル エルエルシー | 上部尿路への薬剤の局所的な送達装置及び方法 |
| GB201505527D0 (en) | 2015-03-31 | 2015-05-13 | Jmedtech Pte Ltd | Composition |
| US10894150B2 (en) | 2015-04-23 | 2021-01-19 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| US20180199816A1 (en) * | 2015-05-26 | 2018-07-19 | Taris Biomedical Llc | Urodynamic assessment sysrems and methods |
| US10159850B2 (en) | 2016-01-06 | 2018-12-25 | Covidien Lp | Brachytherapy clip and applicator |
| US11185670B2 (en) | 2016-01-26 | 2021-11-30 | Taris Biomedical Llc | Multi-lumen drug delivery devices |
| WO2017151983A1 (en) | 2016-03-02 | 2017-09-08 | Taris Biomedical Llc | Osmotic drug delivery devices and methods of making osmotic drug delivery devices |
| IL262746B (en) | 2016-05-06 | 2022-09-01 | Taris Biomedical Llc | A method for treating urothelial cancer in the lower system |
| US11707611B2 (en) * | 2016-11-08 | 2023-07-25 | W. L. Gore & Associates, Inc. | Implantable apparatus for retention of biological moieties |
| EP3551140A4 (en) | 2016-12-09 | 2020-07-08 | Zenflow, Inc. | SYSTEMS, DEVICES AND METHODS FOR THE PRECISE RELEASE OF AN IMPLANT IN THE PROSTATIC urethra |
| ES2873084T3 (es) | 2017-02-01 | 2021-11-03 | Taris Biomedical Llc | Dispositivos para la administración de fármacos in vivo |
| AU2018306299B2 (en) | 2017-07-25 | 2024-08-08 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| WO2019071246A2 (en) | 2017-10-06 | 2019-04-11 | Foundry Therapeutics, Inc. | IMPLANTABLE DEPOSITS FOR CONTROLLED RELEASE OF ANALGESICS TO TREAT POSTOPERATIVE PAIN, AND DEVICES, SYSTEMS, AND RELATED METHODS |
| SG11202003950WA (en) | 2017-11-08 | 2020-05-28 | Taris Biomedical Llc | Methods of treatment and maintenance therapy for bladder cancer using gemcitabine |
| ES2953556T3 (es) | 2017-12-23 | 2023-11-14 | Teleflex Life Sciences Ltd | Aparato de acoplamiento de tejido expandible |
| US12364792B2 (en) | 2018-01-08 | 2025-07-22 | Foundry Therapeutics, Inc. | Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents |
| WO2019221853A1 (en) | 2018-05-12 | 2019-11-21 | Foundry Therapeutics, Inc. | Implantable depots for the controlled release of therapeutic agents |
| JP2021532155A (ja) | 2018-08-01 | 2021-11-25 | タリス バイオメディカル エルエルシー | トロスピウムを使用した過活動膀胱の治療方法 |
| WO2020047013A1 (en) | 2018-08-28 | 2020-03-05 | Foundry Therapeutics, Inc. | Polymer implants |
| US12440301B2 (en) | 2018-11-07 | 2025-10-14 | Teleflex Life Sciences Llc | System for delivery of a fiducial marker |
| PE20242104A1 (es) | 2021-10-12 | 2024-10-28 | Taris Biomedical Llc | Formulaciones y sistemas de erdafitinib para administracion intravesical |
| JP2024545460A (ja) | 2021-12-21 | 2024-12-06 | タリス バイオメディカル エルエルシー | 膀胱内デバイスのための泌尿器配置カテーテル |
| JP2025507590A (ja) | 2022-02-18 | 2025-03-21 | タリス バイオメディカル エルエルシー | エルダフィチニブ製剤及び膀胱内投与のための浸透圧システム |
| US12426818B2 (en) | 2022-06-08 | 2025-09-30 | Bright Uro, Inc. | Packaging assembly and method of preparing sensing device for insertion into a body cavity to preserve sterility |
| CA3257913A1 (en) | 2022-06-08 | 2023-12-14 | Bright Uro, Inc. | UROLOGICAL DETECTION SYSTEMS AND METHODS |
| US20230397914A1 (en) * | 2022-06-10 | 2023-12-14 | Balt Usa, Llc | Implants, systems, and methods for vascular treatment |
| WO2024092159A1 (en) | 2022-10-28 | 2024-05-02 | Taris Biomedical Llc | Methods of treating bladder cancer with gemcitabine |
| KR20250143348A (ko) | 2023-02-13 | 2025-10-01 | 타리스 바이오메디컬 엘엘씨 | 방광암 치료에 사용하기 위한 방광내 투여용 에르다피티닙 |
| CN120731077A (zh) | 2023-02-17 | 2025-09-30 | 塔里斯生物医药公司 | 膀胱内施用厄达替尼以用于治疗膀胱癌 |
| WO2024215682A1 (en) | 2023-04-10 | 2024-10-17 | Taris Biomedical Llc | Gemcitabine for use in methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guerin therapy |
| CN117017567B (zh) * | 2023-08-12 | 2024-04-09 | 上海市第一人民医院 | 一种植入式膀胱收缩系统、工作方法及人造膀胱 |
| WO2025059602A1 (en) | 2023-09-14 | 2025-03-20 | Taris Biomedical Llc | Methods of treating bladder cancer using intravesical administration of erdafitinib |
| TW202532086A (zh) | 2023-10-02 | 2025-08-16 | 美商塔里斯生物醫學有限責任公司 | 治療對卡介苗療法無反應之高風險非肌肉侵襲性膀胱癌之方法 |
| GB202401392D0 (en) * | 2024-02-02 | 2024-03-20 | Imphatec Ltd | Implant for delivery of a drug |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4016251A (en) * | 1972-08-17 | 1977-04-05 | Alza Corporation | Vaginal drug dispensing device |
| US3935860A (en) * | 1974-08-21 | 1976-02-03 | Alza Corporation | Intrauterine device with restrictor for maintaining device in uterine cavity |
| US4968507A (en) | 1984-06-20 | 1990-11-06 | Merck & Co., Inc. | Controlled porosity osmotic pump |
| US4871542A (en) * | 1987-04-30 | 1989-10-03 | Ferring Service Center, N.V. | Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract |
| GB2206046B (en) * | 1987-06-25 | 1991-04-03 | Alza Corp | Multi-unit delivery system |
| AU2867492A (en) * | 1991-10-10 | 1993-05-03 | Alza Corporation | Osmotic drug delivery devices with hydrophobic wall materials |
| DE69329407T2 (de) | 1992-06-02 | 2001-05-03 | Bard Inc C R | Verfahren und Implantatvorrichtung für Langzeitwirkstoffabgabe |
| US5516522A (en) * | 1994-03-14 | 1996-05-14 | Board Of Supervisors Of Louisiana State University | Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same |
| US6171298B1 (en) * | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
| US6039967A (en) * | 1997-04-03 | 2000-03-21 | Point Biomedical Corporation | Intravesical drug delivery system |
| US6982091B2 (en) * | 2001-08-29 | 2006-01-03 | Umd, Inc. | Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy |
| US6749617B1 (en) * | 1997-11-04 | 2004-06-15 | Scimed Life Systems, Inc. | Catheter and implants for the delivery of therapeutic agents to tissues |
| TR200002450T2 (tr) | 1998-02-23 | 2001-01-22 | Massachusetts Institute Of Technology | Şekil belleği olan biyobozunur polimerler. |
| US6183461B1 (en) * | 1998-03-11 | 2001-02-06 | Situs Corporation | Method for delivering a medication |
| US6159143A (en) * | 1998-06-17 | 2000-12-12 | Scimed Life Systems, Inc. | Method and device for delivery of therapeutic agents in conjunction with isotope seed placement |
| US6293923B1 (en) * | 1999-03-15 | 2001-09-25 | Innoventions, Inc. | Intravesicular balloon |
| US7135311B1 (en) * | 1999-05-05 | 2006-11-14 | Institut Curie | Means for detecting and treating pathologies linked to FGFR3 |
| US6139535A (en) | 1999-05-27 | 2000-10-31 | Situs Corporation | Method and apparatus for placement and activation of a medical device within a body cavity |
| JP2003516343A (ja) | 1999-12-10 | 2003-05-13 | マサチューセッツ インスティテュート オブ テクノロジー | 分子を送達するマイクロチップ素子およびその製作方法 |
| US7470228B2 (en) * | 2000-04-14 | 2008-12-30 | Attenuex Technologies, Inc. | Method of treating benign hypertrophy of the prostate |
| US6682473B1 (en) * | 2000-04-14 | 2004-01-27 | Solace Therapeutics, Inc. | Devices and methods for attenuation of pressure waves in the body |
| US6749553B2 (en) * | 2000-05-18 | 2004-06-15 | Theragenics Corporation | Radiation delivery devices and methods for their manufacture |
| US6398718B1 (en) * | 2000-06-15 | 2002-06-04 | Innoventions, Inc. | Intravesicular device |
| AU2002341959A1 (en) * | 2001-10-04 | 2003-04-14 | Case Western Reserve University | Drug delivery devices and methods |
| US8685427B2 (en) | 2002-07-31 | 2014-04-01 | Boston Scientific Scimed, Inc. | Controlled drug delivery |
| GB2385273B (en) * | 2002-02-13 | 2004-05-26 | Deborah Huang | Drug delivery device |
| US6949125B2 (en) | 2002-04-16 | 2005-09-27 | Boston Scientific Scimed, Inc. | Ureteral stent with end-effector and related methods |
| GB0211286D0 (en) | 2002-05-16 | 2002-06-26 | Nokia Corp | Routing data packets through a wireless network |
| DE10247689A1 (de) * | 2002-10-12 | 2004-04-22 | Martin Rahe | Implantat in der Harnblase |
| EP1553899A4 (en) * | 2002-10-22 | 2006-10-25 | METHOD AND SYSTEM FOR INTRAVASCULAR DELIVERY OF THERAPEUTIC AGENTS | |
| AU2003301005A1 (en) | 2002-12-16 | 2004-07-22 | The Regents Of The University Of Michigan | Assembly and planar structure for use therein which is expandable into a 3-d structure such as a stent and device for making the planar structure |
| US20050228482A1 (en) * | 2003-09-26 | 2005-10-13 | William Herzog | Stent covered by a layer having a layer opening |
| WO2005077276A2 (en) | 2004-02-11 | 2005-08-25 | Ethicon, Inc. | System and method for urodynamic evaluation utilizing micro-electronic mechanical system |
| US7862552B2 (en) * | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
| JP5265359B2 (ja) * | 2005-08-11 | 2013-08-14 | マサチューセッツ インスティテュート オブ テクノロジー | 膀胱内薬物送達デバイスおよび方法 |
| US20070255222A1 (en) | 2006-03-27 | 2007-11-01 | Changqing Li | Catheter assembly including internal bolster |
| JP5191489B2 (ja) | 2006-08-23 | 2013-05-08 | エスヴイアイピー 2 エルエルシー | 摂食行動を変更するデバイス及び方法 |
| US20100076261A1 (en) * | 2006-09-28 | 2010-03-25 | Medvision Inc. | Examination device |
| US8128576B2 (en) | 2006-12-07 | 2012-03-06 | Ethicon, Inc. | System and method for urodynamic evaluation utilizing micro electro-mechanical system technology |
| MX348005B (es) * | 2007-12-11 | 2017-05-23 | Massachusetts Inst Technology | Dispositivo implantable de liberación de fármacos y métodos para tratar la vejiga y otras vesículas o lúmenes corporales. |
| EP2257250A2 (en) * | 2008-01-29 | 2010-12-08 | Gilbert H. Kliman | Drug delivery devices, kits and methods therefor |
| CA2733468C (en) * | 2008-08-09 | 2017-12-05 | Massachusetts Institute Of Technology | Implantable drug delivery device and methods of treating male genitourinary and surrounding tissues |
| US20100048266A1 (en) | 2008-08-19 | 2010-02-25 | Samsung Electronics Co., Ltd. | Antenna device |
| JP5913095B2 (ja) * | 2009-06-26 | 2016-04-27 | タリス バイオメディカル エルエルシー | 植込み型薬物送達装置及びその作製方法 |
| US9017312B2 (en) * | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| EP3884988B1 (en) * | 2009-12-17 | 2025-06-18 | TARIS Biomedical LLC | Implantable device with intravesical tolerability |
-
2010
- 2010-12-17 EP EP21157457.9A patent/EP3884988B1/en active Active
- 2010-12-17 HR HRP20210329TT patent/HRP20210329T1/hr unknown
- 2010-12-17 LT LTEP21157457.9T patent/LT3884988T/lt unknown
- 2010-12-17 ES ES10801519T patent/ES2867399T3/es active Active
- 2010-12-17 WO PCT/US2010/061161 patent/WO2011084712A1/en not_active Ceased
- 2010-12-17 PL PL10801519T patent/PL2512581T3/pl unknown
- 2010-12-17 US US12/972,364 patent/US8679094B2/en active Active
- 2010-12-17 PT PT108015199T patent/PT2512581T/pt unknown
- 2010-12-17 EP EP10801519.9A patent/EP2512581B1/en active Active
- 2010-12-17 RS RS20250812A patent/RS67130B1/sr unknown
- 2010-12-17 SM SM20210236T patent/SMT202100236T1/it unknown
- 2010-12-17 PL PL21157457.9T patent/PL3884988T3/pl unknown
- 2010-12-17 SM SM20250293T patent/SMT202500293T1/it unknown
- 2010-12-17 HR HRP20250946TT patent/HRP20250946T1/hr unknown
- 2010-12-17 CA CA2784601A patent/CA2784601C/en active Active
- 2010-12-17 SI SI201032160T patent/SI3884988T1/sl unknown
- 2010-12-17 AU AU2010339821A patent/AU2010339821B2/en active Active
- 2010-12-17 DK DK10801519.9T patent/DK2512581T3/da active
- 2010-12-17 DK DK21157457.9T patent/DK3884988T3/da active
- 2010-12-17 SI SI201032058T patent/SI2512581T1/sl unknown
- 2010-12-17 HU HUE10801519A patent/HUE053888T2/hu unknown
- 2010-12-17 JP JP2012544930A patent/JP2013514837A/ja active Pending
- 2010-12-17 PT PT211574579T patent/PT3884988T/pt unknown
- 2010-12-17 LT LTEP10801519.9T patent/LT2512581T/lt unknown
- 2010-12-17 FI FIEP21157457.9T patent/FI3884988T3/fi active
- 2010-12-17 RS RS20210244A patent/RS61980B1/sr unknown
- 2010-12-17 ES ES21157457T patent/ES3038403T3/es active Active
-
2014
- 2014-03-25 US US14/224,256 patent/US11065426B2/en active Active
-
2015
- 2015-10-26 JP JP2015209758A patent/JP6247270B2/ja active Active
-
2017
- 2017-07-31 JP JP2017147685A patent/JP6854210B2/ja active Active
-
2021
- 2021-04-28 CY CY20211100370T patent/CY1124354T1/el unknown
- 2021-05-04 US US17/307,082 patent/US11890439B2/en active Active
-
2024
- 2024-01-19 US US18/417,811 patent/US20240198067A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013514837A5 (OSRAM) | ||
| HRP20250946T1 (hr) | Intravezikalno podnošljiv implantabilni uređaj | |
| JP7291025B2 (ja) | 薬剤の活性剤をin-situ放出させるための滞留装置及びシステム | |
| JP2016532505A5 (OSRAM) | ||
| Nayak et al. | Gastroretentive drug delivery technologies: Current approaches and future potential | |
| WO2011151830A3 (en) | Gastric anchor | |
| AR041562A1 (es) | Preparacion de liberacion controlada | |
| EP2858604B1 (en) | Expanded device | |
| JP2010174030A5 (OSRAM) | ||
| JP2011505988A5 (OSRAM) | ||
| WO2008148798A3 (en) | Controlled release pharmaceutical compositions for prolonged effect | |
| JP2015529688A5 (OSRAM) | ||
| BRPI0815577A2 (pt) | Peptídeo foxm1 e agente medicinal compreendendo o mesmo. | |
| JP2017508749A5 (OSRAM) | ||
| HRP20251264T1 (hr) | Sustavi za primjenu lijeka i metode za liječenje karcinoma mokraćnog mjehura gemcitabinom | |
| JP2012509124A5 (OSRAM) | ||
| JP2009516719A5 (OSRAM) | ||
| PA8615501A1 (es) | Formulaciones farmaceuticas transdermicas | |
| JP2013505251A5 (OSRAM) | ||
| ES2572180T3 (es) | Formulaciones de liberación controlada que comprenden unidad(es) discreta(s) sin recubrimiento y una matriz de liberación prolongada | |
| Nayak et al. | Gastroretentive drug delivery technologies: Current approaches and future. | |
| JP2006516279A5 (OSRAM) | ||
| RU2004121780A (ru) | Способ лечения | |
| Xiao et al. | Emerging novel hydrogels application in oral and gastrointestinal diseases: design wet adhesive strategy towards possible mechanisms | |
| US20110264055A1 (en) | Medical Device |